or Try an Advanced Search...

    Technical Analysis for CHRO - Chromocell Therapeutics Corporation

    Grade Last Price % Change Price Change
    D 1.46 13.18% 0.17
    CHRO closed up 13.18 percent on Friday, July 26, 2024, on 4.25 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Up Up
    Historical CHRO trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    Crossed Above 50 DMA Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Wide Bands Range Expansion 0.00%
    Above Upper BB Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Crossed Above 20 DMA Bullish 13.18%
    Inside Day Range Contraction 13.18%
    Fell Below 20 DMA Bearish 24.79%
    Older End-of-Day Signals for CHRO ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Support about 11 hours ago
    Down 5% about 11 hours ago
    Down 3% about 11 hours ago
    Down 2 % about 11 hours ago
    Down 1% about 11 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CHRO Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound is CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as for the treatment of eye pain and neuropathic pain. The company was founded in 2002 and is based in Freehold, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pain Neuropathic Pain Erythromelalgia Sodium Channel Blockers

    Is CHRO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 15 Chromocell to Participate in the Virtual Investor Lunch Break Series
    May 13 Chromocell To Present at Alliance Global Partner’s Healthcare Company Showcase on Tuesday, May 21, 2024
    Mar 21 Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
    Mar 18 Chromocell appoints Frank Knuettel as CEO, removing interim status
    Mar 18 Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
    Mar 12 Sidoti Events, LLC's Virtual March Small-Cap Conference
    Feb 27 Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions
    Feb 21 Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million
    Feb 16 Chromocell stock down 11% following $7M IPO
    Feb 16 Chromocell Therapeutics prices upsized $6.6M IPO at $6 per share
    See more CHRO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.0
    52 Week Low 1.06
    Average Volume 20,857
    200-Day Moving Average 0.00
    50-Day Moving Average 1.38
    20-Day Moving Average 1.22
    10-Day Moving Average 1.20
    Average True Range 0.17
    RSI (14) 57.98
    ADX 17.43
    +DI 28.25
    -DI 12.58
    Chandelier Exit (Long, 3 ATRs) 0.98
    Chandelier Exit (Short, 3 ATRs) 1.56
    Upper Bollinger Bands 1.41
    Lower Bollinger Band 1.02
    Percent B (%b) 1.12
    BandWidth 32.37
    MACD Line -0.03
    MACD Signal Line -0.07
    MACD Histogram 0.0353
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.88
    Resistance 3 (R3) 1.84 1.65 1.81
    Resistance 2 (R2) 1.65 1.55 1.67 1.79
    Resistance 1 (R1) 1.56 1.48 1.60 1.60 1.76
    Pivot Point 1.37 1.37 1.40 1.40 1.37
    Support 1 (S1) 1.28 1.27 1.33 1.32 1.16
    Support 2 (S2) 1.09 1.20 1.12 1.13
    Support 3 (S3) 1.00 1.09 1.11
    Support 4 (S4) 1.04